Acute Leukemia In Remission: Disease Bioinformatics
Leukemia is the most common blood cancer, it affects adults 10 times more often than children, but it is the most common childhood cancer. Leukemia causes the bone marrow to produce abnormal white blood cells, these cells do not die when they should and may crowd normal healthy cells, making healthy cells unable to function. In Acute Leukemia, the leukemic cells cannot do the white blood cells functions and the number of leukemic cells increases rapidly. Acute Leukemia usually worsens quickly. Generally men are more likely to be diagnosed with Leukemia than women. The number of new cases diagnosed each year has remained steady for the past 20 years, while the morality rates have greatly decreased. There are many risk factors that greatly increase the odds of developing leukemia such as smoking, chemical exposure, radiation and certain inherited diseases.
Acute Leukemia In Remission Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Acute Leukemia In Remission below!
For more information on how to use Laverne, please read the How to Guide.
We have 1730 products for the study of Acute Leukemia In Remission that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.